> Skip repeated content
photo of Sarah Faith Taber, MD

Sarah Faith Taber, MD

Lerner Children's Pavilion at Hospital for Special Surgery logoPediatrics, Rheumatology

About Dr. Taber

loading...
 

Dr. Sarah Taber specializes in the diagnosis and treatment of children with rheumatic diseases, including juvenile idiopathic arthritis, childhood systemic lupus, dermatomyositis, vasculitis, and systemic and localized scleroderma. She graduated Phi Beta Kappa and Magna Cum Laude from Yale University, and from the Icahn School of Medicine at Mount Sinai, which she attended through the prestigious Humanities and Medicine program.

Dr. Taber completed her residency in pediatrics at NYU Medical Center, where she was selected Outstanding Floor Senior Resident upon graduation. She then completed her fellowship in pediatric rheumatology at Hospital for Special Surgery and Weill Cornell Medical Center. Dr. Taber has been a featured speaker for the Scleroderma Foundation, Charla de Lupus, Arthritis Foundation, and A Lasting Mark Foundation, and is a Consult Editor of Rheumatology for Medscape. She is a member of the Scleroderma, Vasculitis and Rare Diseases group of the Childhood Arthritis and Rheumatology Research Alliance. She is board certified in both pediatrics and pediatric rheumatology.

Departments

Special Expertise

Childhood arthritis, childhood systemic lupus erythematosus, vasculitis, localized scleroderma, systemic sclerosis, juvenile dermatomyositis, fever of unknown origin, autoinflammatory disease

Patient Stories

Videos

Patient ratings for Dr. Taber

loading...

Learn more about our patient ratings.

Insurance

Please do not hesitate to contact our office if you have questions regarding your insurance coverage. You may have coverage subject to the availability of 'out-of-network' benefits.

Credentials

Appointments

Assistant Attending Physician, Hospital for Special Surgery
Assistant Professor of Pediatrics, Weill Cornell Medical College

Affiliations

American College of Rheumatology
American Academy of Pediatrics
Childhood Arthritis and Rheumatology Research Alliance (CARRA)

Certification

American Board of Pediatrics

Awards

Phi Beta Kappa, 2005
Magna Cum Laude, 2005

Education

Yale University (Undergraduate)
Icahn School of Medicine at Mount Sinai

Internship

New York University School of Medicine

Residency

New York University School of Medicine

Fellowship

Hospital for Special Surgery, New York

State Licensure

Languages

English

Publications by Dr. Taber

Patient Education

Blog Posts

Selected Journal Articles

Trachtman R, Wang C, Murray E, Szymonifka J, Pan N, Adams A, Taber S, Onel K, Mandl L. “PROMIS Computer Adaptive Tests and Their Correlation with Disease Activity in Juvenile Idiopathic Arthritis.” Journal of Clinical Rheumatology, June 2021, Volume 27, Issue 4.

Torok K, Li C, Jacobe H, Taber S, Stevens A, Zulian F, and Lu T. “Immunopathogenesis of Pediatric Localized Scleroderma.” Frontiers in Immunology, 30 April 2019. 

Lehman T, Taber S, Nuruzzaman F. “Systemic Lupus Erythematosus in Childhood and Adolescence.” Dubois’ Lupus Erythematosus and Related Syndromes pp520-531. Elsevier (2019).

Trachtman R, Adams A, Pan N, Taber S, Onel K. "Oxygen saturation recordings in pediatric rheumatology patients at risk for lung disease." Pediatric Rheumatology Symposium, American College of Rheumatology; Houston TX; May 2017.

Lehman T, Nuruzzaman F, Taber S. “Systemic lupus erythematosus: etiology, pathogenesis, clinical manifestations, and management.” Handbook of Systemic Autoimmune Diseases Volume 6: Pediatrics in Systemic Autoimmune Diseases pp173-190. Cambridge, MA: Elsevier (2016).

Walters H, Pan N, Lehman TJ, Adams A, Huang W, Sitaras L, Singh C, Nuruzzaman F, Taber S. “A prospective study comparing infectious risks, disease activity, and cytokine alterations in children with juvenile idiopathic arthritis treated with and without tumor necrosis factor-alpha inhibitors.” Pediatric Rheumatology Symposium, American College of Rheumatology; Orlando FL; April 2014.

Greene AK, Taber SF, Ball KL, Padwa BL, Mulliken JB. Sturge-Weber syndrome: soft-tissue and skeletal overgrowth. J Craniofac Surg. 2009 Mar; 20 Suppl 1:617-21. PMID: 19182685.

For more publications, please see the PubMed listing.

Selected Presentations

Trachtman R, Murray E, Szymonifka J, Adams A, Pan N, Taber S, Lehman T, Onel K, Mandl L. Do Patient Reported Outcome Measurement Information System (PROMIS) Computer Adaptive Tests Correlate with Disease Activity in Juvenile Idiopathic Arthritis? PHO Conference: PROMIS in Action, Poster Presentation

Trachtman R, Murray E, Szymonifka J, Toussi S, Nellis M, Adams A, Pan N, Taber S, Lehman T, Onel K, Mandl L. Procalcitonin Differentiates Infection from Active Disease in Patients with Juvenile Idiopathic Arthritis. ACR/ARHP Annual Meeting 2017, Poster Presentation

Treemarcki E, Syzmonifka J, Adams A, Pan N, Taber S, Onel K. “A Weighty Diagnosis: Weight Change and Risk Factors in Early Juvenile Systemic Lupus Erythematosus.” ACR/ARHP Annual Meeting 2018, Poster Presentation 

Professional Education by Dr. Taber on HSS.edu

Research

Research Interests

Localized scleroderma, systemic sclerosis, whole genome sequencing, gene expression studies

Industry Relationships

Industry Relationships

One of the goals of HSS is to advance the science of orthopedic surgery, rheumatology, and related disciplines for the benefit of patients. Physicians at HSS may collaborate with outside companies for education, research and medical advances. HSS supports this collaboration in order to foster medical breakthroughs; however HSS also believes that these collaborations must be disclosed.

As part of the disclosure process, this website lists physician collaborations with outside companies. The disclosures are provided by information provided by the physician and other sources and are updated regularly. Further information may be available on individual company websites.

As of November 18, 2019, Dr. Taber reported no relationships with healthcare industry.

By disclosing the collaborations of HSS physicians with industry on this website, HSS and its physicians make this information available to their patients and the public, thus creating a transparent environment for those who are interested in this information. Further, the HSS Conflicts of Interest Policy does not permit physicians to collect royalties on products developed by him/her that are used on patients at HSS.

Dr. Taber in the News